Related Experiment Videos
Cochlioquinone A, a nematocidal agent which competes for specific [3H]ivermectin binding sites
J M Schaeffer1, E G Frazier, A R Bergstrom
1Department of Biochemical Parasitology, Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065.
The Journal of Antibiotics
|September 1, 1990
Summary
Cochlioquinone A from Helminthosporium sativum fungus exhibits nematocidal activity. This compound competitively inhibits [3H]ivermectin binding, indicating a shared membrane receptor interaction.
Area of Science:
- Mycology
- Parasitology
- Biochemistry
Background:
- Nematodes are significant agricultural and health pests.
- Fungal metabolites are a source of novel bioactive compounds.
- Ivermectin is a broad-spectrum antiparasitic drug targeting glutamate-gated chloride channels.
Purpose of the Study:
- To investigate the biological activity of Cochlioquinone A.
- To determine the mechanism of action for Cochlioquinone A's nematocidal effects.
- To explore potential interactions between Cochlioquinone A and known antiparasitic drug targets.
Main Methods:
- Isolation and purification of Cochlioquinone A from Helminthosporium sativum.
- Assay of nematocidal activity against specific nematode species.
- Radioligand binding assays to assess [3H]ivermectin binding inhibition.
Main Results:
- Cochlioquinone A demonstrated significant nematocidal activity.
- Cochlioquinone A acted as a competitive inhibitor of specific [3H]ivermectin binding.
- The results suggest Cochlioquinone A and ivermectin bind to the same membrane receptor.
Conclusions:
- Cochlioquinone A is a potent natural nematicide.
- The mechanism of action involves interaction with the ivermectin receptor.
- Cochlioquinone A represents a potential lead compound for new anthelmintic drug development.